We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Technologic Advancements Drive European C-arms Market

By MedImaging staff writers
Posted on 20 Oct 2006
Print article
The need to replace existing image intensifier based systems with flat panel detectors (FPDs) is driving the European C-arms market. This trend has been spurred by the need for complete workflow integration in a fully digital radiology environment. Moreover, FPDs provide improved, distortion-free images in comparison to image intensifiers. However, their high cost, combined with a lack of funding for healthcare projects, will pose an important limitation to their adoption in the mobile C-arms segment.

Frost & Sullivan (Palo Alto, CA, USA), an international growth consultancy company, found that the European C-arms market earned revenues of U.S.$375.2 million in 2005 and estimates this will reach $548.8 million in 2012.

"New systems fitted with FPDs instead of conventional image intensifiers are replacing fixed C-arm systems across Europe,” noted Frost & Sullivan medical imaging team leader, Arun B. Karthik. "This trend will be evident in mobile C-arms too by the year 2008 and will be the single, most important factor driving this market.”

FPDs make the C-arm system intrinsically digital and eliminate the need for analog-to-digital conversion of images captured using an image intensifier. Furthermore, they are lighter and more compact, enabling maneuverability and ease of handling during procedures using mobile C-arm systems. In addition, FPDs provide distortion-free images. These advantages, combined with the push towards a completely digital radiology environment, will motivate the C-arms market to completely convert to FPDs.

However, mainly due to their high cost, FPDs are not yet being widely adopted by mobile C-arm users and vendors. Even with fixed C-arms, FPDs increase the cost of systems. Furthermore, with Europe being on a capital investment model, C-arms--particularly mobile systems--tend to take a back seat when it comes to resource allocation, resulting in prolonged replacement cycles.

"The lack of investment in healthcare across Europe has led to price pressures in the C-arms market,” explained Mr. Karthik. "This situation has hindered faster adoption of FPDs in fixed C-arms and has completely prevented its use in mobile C-arms, so much so that only one vendor has introduced an FPD-based mobile C-arm in the market.”

The focus of C-arm system vendors should be to develop an FPD that is both efficient and cost-effective. This would require continued investments in R&D and sustained adoption of FPDs in the fixed C-arm domain. An aggressive, vendor-backed campaign detailing the benefits of FPDs will ensure strong growth for the European C-arms market.



Related Links:
Frost & Sullivan
New
Medical Radiographic X-Ray Machine
TR30N HF
Portable X-ray Unit
AJEX140H
New
Post-Processing Imaging System
DynaCAD Prostate
New
Mammography System (Analog)
MAM VENUS

Print article

Channels

Radiography

view channel
Image: The new machine algorithm can identify cardiovascular risk at the click of a button (Photo courtesy of Adobe Stock)

Machine Learning Algorithm Identifies Cardiovascular Risk from Routine Bone Density Scans

A new study published in the Journal of Bone and Mineral Research reveals that an automated machine learning program can predict the risk of cardiovascular events and falls or fractures by analyzing bone... Read more

MRI

view channel
Image: In brains of control mice (left) and PD mice (right), from bottom to top: neuronal activity in a representative animal (Photo courtesy of Ruxanda Lungu/FC)

Simple Brain Scan Diagnoses Parkinson's Disease Years Before It Becomes Untreatable

Parkinson's disease (PD) remains a challenging condition to treat, with no known cure. Though therapies have improved over time, and ongoing research focuses on methods to slow or alter the disease’s progression,... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.